Covishield Vaccines
-
{
- All
- News
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
"Sympathy Goes Out...": AstraZeneca Amid Vaccine's Side Effects Concerns
Amid concerns regarding potential side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant on Tuesday reiterated its commitment to patient safety.
-
Serum Institute To Provide 2 Crore Covishield Doses To Centre For Free
The Serum Institute of India has offered two crore doses of Covishield vaccine to the central government free of cost amid a rise in COVID-19 cases in some countries, official sources said today.
-
Reports That 50 Lakh Covishield Doses May Go Waste This Month "Misleading": Centre
The Union Health Ministry today refuted as "misleading" media reports which claimed that 50 lakh unused Covishield doses may go waste by the end of this month.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
-
Jharkhand Man, Paralysed, Claims He's Able To Move After Vaccination
A 55-year-old man, who had become paralysed and lost his voice four years ago in an accident, said he was able to move and speak after he was given Covishield vaccine on January 4.
-
AstraZeneca Covid Vaccine Protection Wanes After 3 Months: Lancet Study
The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to a study published in The Lancet journal.
-
Airlifting Of Covishield Vaccine Will Continue During Closure Of Pune Airport: Air Force
The Indian Air Force on Wednesday said it will ensure that transportation of the Covishield vaccine will not be disrupted during a planned 14-day closure of the runway at the Pune International Airport.
-
"I Got India's Covishield Vaccine": UN General Assembly President Abdulla Shahid
President of the 76th session of the UN General Assembly Abdulla Shahid has said he had received the two doses of the Covishield vaccine manufactured in India, as have a "large portion" of other countries around the world.
-
Centre Warns States About Fake Vaccines, Explains How To Identify
With reports of counterfeit versions of Covishield vaccines circulating in the international market - a concern flagged by even the World Health Organization, the Centre on Saturday shared a list of parameters to identify the authenticity of the Covi
-
84-Day Gap Between Covishield Jabs Providing Best Protection Against Covid: Centre To Court
The Central government has submitted in the Kerala High Court on Friday that the duration of 84 days between 1st and 2nd doses of Covishield vaccine is providing the best protection against COVID-19.
-
Now, African Nations Flag EU Excluding Covishield For 'Vaccine Passport'
Days after it was red-flagged in India, the European Union's decision to exclude Covishield from a list of approved Covid vaccines for a 'passport' - to allow holders restriction-free travel in the bloc - has set alarm bells ringing in Africa.
-
Covishield, Covaxin Work Against Alpha, Beta, Gamma, Delta Variants: Centre
Vaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said on Friday.
-
AstraZeneca COVID-19 Vaccine Linked With Small Risk Of Low Blood Platelets: Study
The Oxford-AstraZeneca vaccine, also known as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK.
-
Covishield Produced More Antibodies Than Covaxin In Early Study: Report
Covishield vaccine produced more antibodies than Covaxin, according to a preliminary study by Coronavirus Vaccine-induced Antibody Titre (COVAT) involving healthcare workers (HCW) who have received both doses of either of the two vaccines.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
"Sympathy Goes Out...": AstraZeneca Amid Vaccine's Side Effects Concerns
Amid concerns regarding potential side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant on Tuesday reiterated its commitment to patient safety.
-
Serum Institute To Provide 2 Crore Covishield Doses To Centre For Free
The Serum Institute of India has offered two crore doses of Covishield vaccine to the central government free of cost amid a rise in COVID-19 cases in some countries, official sources said today.
-
Reports That 50 Lakh Covishield Doses May Go Waste This Month "Misleading": Centre
The Union Health Ministry today refuted as "misleading" media reports which claimed that 50 lakh unused Covishield doses may go waste by the end of this month.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
-
Jharkhand Man, Paralysed, Claims He's Able To Move After Vaccination
A 55-year-old man, who had become paralysed and lost his voice four years ago in an accident, said he was able to move and speak after he was given Covishield vaccine on January 4.
-
AstraZeneca Covid Vaccine Protection Wanes After 3 Months: Lancet Study
The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to a study published in The Lancet journal.
-
Airlifting Of Covishield Vaccine Will Continue During Closure Of Pune Airport: Air Force
The Indian Air Force on Wednesday said it will ensure that transportation of the Covishield vaccine will not be disrupted during a planned 14-day closure of the runway at the Pune International Airport.
-
"I Got India's Covishield Vaccine": UN General Assembly President Abdulla Shahid
President of the 76th session of the UN General Assembly Abdulla Shahid has said he had received the two doses of the Covishield vaccine manufactured in India, as have a "large portion" of other countries around the world.
-
Centre Warns States About Fake Vaccines, Explains How To Identify
With reports of counterfeit versions of Covishield vaccines circulating in the international market - a concern flagged by even the World Health Organization, the Centre on Saturday shared a list of parameters to identify the authenticity of the Covi
-
84-Day Gap Between Covishield Jabs Providing Best Protection Against Covid: Centre To Court
The Central government has submitted in the Kerala High Court on Friday that the duration of 84 days between 1st and 2nd doses of Covishield vaccine is providing the best protection against COVID-19.
-
Now, African Nations Flag EU Excluding Covishield For 'Vaccine Passport'
Days after it was red-flagged in India, the European Union's decision to exclude Covishield from a list of approved Covid vaccines for a 'passport' - to allow holders restriction-free travel in the bloc - has set alarm bells ringing in Africa.
-
Covishield, Covaxin Work Against Alpha, Beta, Gamma, Delta Variants: Centre
Vaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said on Friday.
-
AstraZeneca COVID-19 Vaccine Linked With Small Risk Of Low Blood Platelets: Study
The Oxford-AstraZeneca vaccine, also known as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK.
-
Covishield Produced More Antibodies Than Covaxin In Early Study: Report
Covishield vaccine produced more antibodies than Covaxin, according to a preliminary study by Coronavirus Vaccine-induced Antibody Titre (COVAT) involving healthcare workers (HCW) who have received both doses of either of the two vaccines.
